Diabetic Gastroparesis Treatment Global Market Report 2024

Description

Diabetic gastroparesis is a condition characterized by damage to the stomach muscles and nerves due to high blood glucose levels, resulting in delayed gastric emptying and associated symptoms. Diabetic gastroparesis treatment involves medical interventions and management strategies aimed at alleviating symptoms and improving the overall well-being of individuals affected by this condition. The treatment approach encompasses various interventions to address delayed stomach emptying and related gastrointestinal symptoms.

The primary treatments for diabetic gastroparesis include medication and surgery. Medications, such as gastroprokinetic agents, antiemetic agents, and botulinum toxin, are utilized for the diagnosis, treatment, prevention, or alleviation of symptoms associated with this medical condition. These medications are administered orally or via injections and are distributed through hospital pharmacies, retail pharmacies, and other channels catering to hospitals, homecare, specialty clinics, and similar healthcare settings.

The diabetic gastroparesis treatment market research report is one of a series of new reports from The Business Research Company that provides diabetic gastroparesis treatment market statistics, including diabetic gastroparesis treatment industry global market size, regional shares, competitors with a diabetic gastroparesis treatment market share, detailed diabetic gastroparesis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the diabetic gastroparesis treatment industry. This diabetic gastroparesis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetic gastroparesis treatment market size has grown strongly in recent years. It will grow from $3.68 billion in 2023 to $3.86 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth observed in the historical period can be attributed to factors such as the increasing prevalence of diabetes, limited treatment options, a rise in awareness and diagnosis of diabetic gastroparesis, and the development of healthcare infrastructure.

The diabetic gastroparesis treatment market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth in the forecast period can be attributed to the adoption of precision medicine and personalized therapies, the growing diabetic population, increased research and development efforts, and a shift in the regulatory landscape. Noteworthy trends expected in the forecast period include technological innovations in treatments, the emergence of novel therapies, a focus on symptom management, the utilization of telemedicine and remote monitoring, and interventions targeting the gut microbiome.

The diabetic gastroparesis treatment market is poised for growth, driven by the increasing prevalence of diabetes. The prevalence of diabetes, indicating the percentage of the population diagnosed with diabetes at a specific time, has led to a growing demand for diabetic gastroparesis treatment. This treatment is crucial for managing symptoms and complications associated with gastroparesis, a common complication of diabetes. For example, as of April 2023, The British Diabetic Association reported that 4.3 million individuals in the UK are living with diabetes, with more than 2.4 million at high risk of type 2 diabetes. The registration numbers for 2021-22 reached 148,951, emphasizing the significant impact of diabetes prevalence on the diabetic gastroparesis treatment market.

The growth of the diabetic gastroparesis treatment market is further fueled by the increase in the prediabetic population. Prediabetic individuals, with elevated blood sugar levels not yet meeting the diabetes diagnosis criteria, represent a substantial portion of the population. The emphasis on effective prevention and treatment strategies for diabetes and its complications, including gastroparesis, is evident. For instance, data from the Centers for Disease Control and Prevention in June 2022 revealed that 96 million people aged 18 or older have prediabetes in the United States, constituting 38.0% of the adult population. The significant prediabetic population is a key driver for the growth of the diabetic gastroparesis treatment market.

The diabetic gastroparesis treatment market is anticipated to experience growth due to the rising number of surgical procedures. Surgical interventions in diabetic patients, such as Nissen fundoplication, gastric bypass surgery, and cholecystectomy, can lead to post-surgical gastroparesis. The increase in surgical procedures, as reported by the Aesthetic Society in April 2022, with a 54% rise in surgical aesthetic procedures in 2021 compared to 2020, contributes to the demand for diabetic gastroparesis treatment.

A notable trend in the diabetic gastroparesis treatment market is the development of new medications. Major companies are actively engaged in creating innovative products to maintain their market positions. In June 2023, the U.S. Food and Drug Administration approved two medications, Empagliflozin (Jardiance) and Synjardy (Empagliflozin and Metformin Hydrochloride), for treating type 2 diabetes in children aged ten and older. This approval marks a significant advancement in diabetes treatment, offering more comprehensive blood sugar management.

Strategic alliances are a key focus for major companies in the diabetic gastroparesis treatment market to enhance their market positions. For instance, in August 2021, Fitbit, a U.S.-based consumer electronics company, entered into an agreement with LifeScan, a U.S.-based diagnostic systems manufacturer in the diabetes market. This alliance aimed to link health tracking apps with glucose monitoring devices, providing diabetes patients access to the OneTouch Reveal app. The integration allows users to sync OneTouch blood glucose data with metrics collected by Fitbit, offering a holistic approach to diabetes management.

Major companies operating in the diabetic gastroparesis treatment market report are Cardinal Health Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Ipca Laboratories Ltd., Abbott Laboratories, GlaxoSmithKline plc, AstraZeneca plc, Medtronics plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Kimberly-Clark Corporation, Teva Pharmaceutical Industries Ltd., Janssen Global Services LLC, Boston Scientific Corporation, Fresenius Kabi AG, Bausch Health Companies Inc., Allergan Inc., Salix Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Wockhardt Ltd., ANI Pharmaceuticals Inc., Endologic LLC, Vanda Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Theravance Biopharma Inc., Neurogastrx Inc., Evoke Pharma Inc., CinRx Pharma LLC

North America was the largest region in the diabetic gastroparesis treatment market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic gastroparesis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the diabetic gastroparesis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The diabetic gastroparesis treatment market consists of revenues earned by entities by providing services such as medical evaluation, medication management, dietary consultation, insulin adjustment, lifestyle modifications, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetic gastroparesis treatment market also includes sales of metoclopramide, erythromycin, domperidone, promethazine, and ondansetron (Zofran). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetic Gastroparesis Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetic gastroparesis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetic gastroparesis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetic gastroparesis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Treatment: Medication; Surgery
2) By Route Of Administration: Oral; Injectables
3) By Indication: Compensated Gastroparesis; Gastric Failure
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Companies Mentioned: Cardinal Health Inc.; Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Ipca Laboratories Ltd.; Abbott Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r14274

1. Executive Summary

2. Diabetic Gastroparesis Treatment Market Characteristics

3. Diabetic Gastroparesis Treatment Market Trends And Strategies

4. Diabetic Gastroparesis Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Diabetic Gastroparesis Treatment Market Size and Growth

5.1. Global Diabetic Gastroparesis Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Diabetic Gastroparesis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Diabetic Gastroparesis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Diabetic Gastroparesis Treatment Market Segmentation

6.1. Global Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Medication
Surgery
6.2. Global Diabetic Gastroparesis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Injectables
6.3. Global Diabetic Gastroparesis Treatment Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Compensated Gastroparesis
Gastric Failure
6.4. Global Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
6.5. Global Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users

7. Diabetic Gastroparesis Treatment Market Regional And Country Analysis

7.1. Global Diabetic Gastroparesis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Diabetic Gastroparesis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Diabetic Gastroparesis Treatment Market

8.1. Asia-Pacific Diabetic Gastroparesis Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Diabetic Gastroparesis Treatment Market

9.1. China Diabetic Gastroparesis Treatment Market Overview
9.2. China Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Diabetic Gastroparesis Treatment Market

10.1. India Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Diabetic Gastroparesis Treatment Market

11.1. Japan Diabetic Gastroparesis Treatment Market Overview
11.2. Japan Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Diabetic Gastroparesis Treatment Market

12.1. Australia Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Diabetic Gastroparesis Treatment Market

13.1. Indonesia Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Diabetic Gastroparesis Treatment Market

14.1. South Korea Diabetic Gastroparesis Treatment Market Overview
14.2. South Korea Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Diabetic Gastroparesis Treatment Market

15.1. Western Europe Diabetic Gastroparesis Treatment Market Overview
15.2. Western Europe Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Diabetic Gastroparesis Treatment Market

16.1. UK Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Diabetic Gastroparesis Treatment Market

17.1. Germany Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Diabetic Gastroparesis Treatment Market

18.1. France Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Diabetic Gastroparesis Treatment Market

19.1. Italy Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Diabetic Gastroparesis Treatment Market

20.1. Spain Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Diabetic Gastroparesis Treatment Market

21.1. Eastern Europe Diabetic Gastroparesis Treatment Market Overview
21.2. Eastern Europe Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Diabetic Gastroparesis Treatment Market

22.1. Russia Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Diabetic Gastroparesis Treatment Market

23.1. North America Diabetic Gastroparesis Treatment Market Overview
23.2. North America Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Diabetic Gastroparesis Treatment Market

24.1. USA Diabetic Gastroparesis Treatment Market Overview
24.2. USA Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Diabetic Gastroparesis Treatment Market

25.1. Canada Diabetic Gastroparesis Treatment Market Overview
25.2. Canada Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Diabetic Gastroparesis Treatment Market

26.1. South America Diabetic Gastroparesis Treatment Market Overview
26.2. South America Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Diabetic Gastroparesis Treatment Market

27.1. Brazil Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Diabetic Gastroparesis Treatment Market

28.1. Middle East Diabetic Gastroparesis Treatment Market Overview
28.2. Middle East Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Diabetic Gastroparesis Treatment Market

29.1. Africa Diabetic Gastroparesis Treatment Market Overview
29.2. Africa Diabetic Gastroparesis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Diabetic Gastroparesis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Diabetic Gastroparesis Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Diabetic Gastroparesis Treatment Market Competitive Landscape And Company Profiles

30.1. Diabetic Gastroparesis Treatment Market Competitive Landscape
30.2. Diabetic Gastroparesis Treatment Market Company Profiles
- 30.2.1. Cardinal Health Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Ipca Laboratories Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Abbott Laboratories
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Diabetic Gastroparesis Treatment Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc
31.2. AstraZeneca plc
31.3. Medtronics plc
31.4. Takeda Pharmaceutical Company Limited
31.5. Eli Lilly and Company
31.6. Kimberly-Clark Corporation
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Janssen Global Services LLC
31.9. Boston Scientific Corporation
31.10. Fresenius Kabi AG
31.11. Bausch Health Companies Inc.
31.12. Allergan Inc.
31.13. Salix Pharmaceuticals Inc.
31.14. Ironwood Pharmaceuticals Inc.
31.15. Wockhardt Ltd.

32. Global Diabetic Gastroparesis Treatment Market Competitive Benchmarking

33. Global Diabetic Gastroparesis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Diabetic Gastroparesis Treatment Market

35. Diabetic Gastroparesis Treatment Market Future Outlook and Potential Analysis

35.1 Diabetic Gastroparesis Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Diabetic Gastroparesis Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Diabetic Gastroparesis Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer